Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.

Chiara Della BellaMichele SpinicciAlessia GrassiFilippo BartalesiMarisa BenagianoKatja TruthmannSimona TapinassiArianna TroiloSofia D'EliosHeba AlnwaisriEduard A ShuralevMahavir SinghAlessandro BartoloniMario Milco D'Elios

Published in: PloS one (2018)

This study demonstrates that the LIOSpot® TB test is a highly useful diagnostic tool to discriminate between latent TB infection and active tuberculosis in adults patients.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
end stage renal disease
hiv aids
ejection fraction
chronic kidney disease
prognostic factors
emergency department
adverse drug
human immunodeficiency virus
hepatitis c virus
drug induced